跳至主要内容
临床试验/JPRN-UMIN000026094
JPRN-UMIN000026094已完成未知

Safety and efficacy of transcatheter arterial micro embolization (TAME) using Imipenem / Cilastatin (IPM/CS) for chronic musculoskeletal pain refractory to non-surgical management. - Safety and efficacy of TAME for chronic musculoskeletal pain refractory to non-surgical management.

Tottori university, Faculty of medicine0 个研究点目标入组 20 人开始时间: 2017年4月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Adaptation of treating surgically. 2)Neoplasm 3)Severe arteriosclerosis 4)Pregnant female, female with the possibility of the pregnancy or nursing female 5)6)Iodine Allergy 7)IPM/CS Allergy 8)Using sodium valproate 9)Patients with the past of hypersensitivity for carbapenem system, penicillin system or cephem antibiotics. 10)Severe depression 11)Uncontrollable severe diabetes mellitus 12)Patients who have difficulty in going to hospital follow-up after this treatment enforcement. 13)Patients who abnormal vessels are not recognized in an angiography.

研究者

发起方
Tottori university, Faculty of medicine

相似试验